Price (delayed)

$163.87

Market cap

$156.73B

P/E Ratio

27

Dividend/share

$2.77

EPS

$6.07

Enterprise value

$172.26B

Sector: Healthcare

Industry: Drug Manufacturers - General

Website: http://www.lilly.com

The equity has increased by 24% year-on-year and by 18% since the previous quarter

The company's gross profit rose by 8% YoY and by 3.9% QoQ

The P/E is 67% above the last 4 quarters average of 16.2 but 38% below the 5-year quarterly average of 43.7

The net income has contracted by 34% from the previous quarter and by 12% YoY

The EPS has decreased by 32% QoQ and by 3.8% YoY

Shares outstanding

956.45M

Market cap

$156.73B

Enterprise value

$172.26B

EBIT

$6.21B

EBITDA

$7.36B

Price to earnings (P/E)

27

Price to book (P/B)

50.9

Price to sales (P/S)

6.45

EV/EBIT

27.72

EV/EBITDA

23.39

Net debt/EBITDA

2.11

EV/Sales

7.46

EBITDA margin

31.9%

Gross margin

79.2%

Net margin

24%

Operating margin

26.9%

Return on assets

14.1%

Return on equity

186.8%

Return on invested capital

20.1%

Return on capital employed

21.8%

Return on sales

26.9%

Debt to equity

5.6

Free cash flow

$3.82B

Free cash flow per share

$4.21

Book value per share

$3.22

Revenue per share

$25.42

TBVPS

$32.54

Current ratio

1.11

Quick ratio

0.64

Working capital

$1.38B

Dividend yield

1.69%

DPS

$2.77

Payout ratio

45.6%

LLY's operating income has surged by 104% year-on-year and by 18% since the previous quarter

ELI LILLY & Co's operating margin has soared by 91% YoY and by 14% from the previous quarter

ELI LILLY & Co's net margin has decreased by 36% from the previous quarter and by 17% YoY

The net income has contracted by 34% from the previous quarter and by 12% YoY

Price to earnings (P/E)
Price to book (P/B)
Price to sales (P/S)

Current price to earnings (P/E):

27

The P/E is 67% above the last 4 quarters average of 16.2 but 38% below the 5-year quarterly average of 43.7

The EPS has decreased by 32% QoQ and by 3.8% YoY

Current price to book (P/B):

50.9

LLY's P/B is 26% above its last 4 quarters average of 40.5

The equity has increased by 24% year-on-year and by 18% since the previous quarter

Current price to sales (P/S):

6.45

The stock's price to sales (P/S) is 40% more than its 5-year quarterly average of 4.6 and 27% more than its last 4 quarters average of 5.1

ELI LILLY & Co's revenue has increased by 7% YoY and by 3.4% from the previous quarter

The company's return on equity has surged by 176% YoY but it fell by 37% QoQ

The ROA has contracted by 35% from the previous quarter and by 4.7% YoY

The ROS has decreased by 33% QoQ and by 14% YoY

The ROIC has contracted by 31% from the previous quarter and by 11% YoY

DPS

$2.77

Dividend yield

1.69%

Payout ratio

45.6%

Assets vs liabilities

LLY's total assets is 8% greater than its total liabilities

LLY's total assets is up by 8% year-on-year and by 4.6% since the previous quarter

ELI LILLY & Co's total liabilities has increased by 7% YoY and by 3.6% from the previous quarter

Debt vs equity

The equity has increased by 24% year-on-year and by 18% since the previous quarter

The company's debt to equity fell by 16% YoY and by 4.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.